My understanding is that there has been a lot of vague reporting out there in the general news media about Follica recently, including articles in the Wall Street Journal, Huffington Post, etc. which are all combining the following:
A lead-in to the story saying that a company called Follica has developed something involving “skin perturbation” which may lead to a cure for baldness. The articles mention a Follica press release by the company’s CEO, Dr. William Ju.
They go on to make some vague statements about tests on humans and “preclinical and clinical trials” that have already been done (we do know that Follica did some trials of the skin perturbation concept in Gemrany a few years ago (about 5 years ago?), but I’ve seen very little information about this, no data or photos, etc. But the articles we’re seeing lately just say they’ve done “clinical trials”. Furthermore the articles don’t make it clear what trials have already done, what trials might be happening now, and what trials are planned. If you read all of these articles very closely, it appears NO trials are happening right now. There is absolutely nothing in any of these articles that indicates that human clinical trials are going on right now, or even that they are imminent.
Various artilces on these subjects on public relations aggregator and investor-oriented sites like Xconomy.com, all over the internet.
Some of the articles mention this recent discovery by Dr. Cotsarelis of Fgf9, and how it has led to new growth in follicles, but no concrete information on how good it is, success rates, growth rates, follicle counts, photographs, etc.
Conclusions? I have my own tentative conclusiona about all of this. I think we REALLY have to read between the lines and pay just as close attention to what has NOT been said, as to what HAS been said… maybe even closer attention.
What have other forum members concluded?